These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1186 related items for PubMed ID: 23209033

  • 1. The definition of primary and secondary glioblastoma.
    Ohgaki H, Kleihues P.
    Clin Cancer Res; 2013 Feb 15; 19(4):764-72. PubMed ID: 23209033
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Analysis of the IDH1 codon 132 mutation in brain tumors.
    Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A.
    Acta Neuropathol; 2008 Dec 15; 116(6):597-602. PubMed ID: 18985363
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Genetic pathways to primary and secondary glioblastoma.
    Ohgaki H, Kleihues P.
    Am J Pathol; 2007 May 15; 170(5):1445-53. PubMed ID: 17456751
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas.
    Ichimura K, Pearson DM, Kocialkowski S, Bäcklund LM, Chan R, Jones DT, Collins VP.
    Neuro Oncol; 2009 Aug 15; 11(4):341-7. PubMed ID: 19435942
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
    Fujisawa H, Kurrer M, Reis RM, Yonekawa Y, Kleihues P, Ohgaki H.
    Am J Pathol; 1999 Aug 15; 155(2):387-94. PubMed ID: 10433932
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
    Roodakker KR, Elsir T, Edqvist PD, Hägerstrand D, Carlson J, Lysiak M, Henriksson R, Pontén F, Rosell J, Söderkvist P, Stupp R, Tchougounova E, Nistér M, Malmström A, Smits A.
    Oncotarget; 2016 Nov 08; 7(45):72431-72442. PubMed ID: 27626492
    [Abstract] [Full Text] [Related]

  • 14. Phenotype vs genotype in the evolution of astrocytic brain tumors.
    Kleihues P, Ohgaki H.
    Toxicol Pathol; 2000 Nov 08; 28(1):164-70. PubMed ID: 10669004
    [Abstract] [Full Text] [Related]

  • 15. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
    Ohgaki H, Kleihues P.
    J Neuropathol Exp Neurol; 2005 Jun 08; 64(6):479-89. PubMed ID: 15977639
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. PDGFRA gain in low-grade diffuse gliomas.
    Motomura K, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Nakazato Y, Tanaka Y, Nonoguchi N, Pierscianek D, Kim YH, Mariani L, Vital A, Perry A, Ohgaki H.
    J Neuropathol Exp Neurol; 2013 Jan 08; 72(1):61-6. PubMed ID: 23242283
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.